Fortitude Advisory Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
TIA
MJRIC
MCM
Fortitude Advisory Group's BBH Position: Q2 2022 in Review
Fortitude Advisory Group sold out of VanEck Biotech ETF (BBH) in Q2 2022, closing a stake of 393 shares — an estimated $64K sold.
Fortitude Advisory Group first reported a position in BBH in Q4 2021 and held it in 2 quarters. The position peaked at $64K in Q1 2022. 108 funds tracked by Wall St. Rank hold BBH as of Q2 2022.
- Fortitude Advisory Group reported no remaining VanEck Biotech ETF position as of Q2 2022 after selling out during the quarter.
- Fortitude Advisory Group sold 393 VanEck Biotech ETF shares in Q2 2022, an estimated $64K.
- Fortitude Advisory Group first reported a position in VanEck Biotech ETF in Q4 2021 and held it in 2 quarters.
- Fortitude Advisory Group's VanEck Biotech ETF position peaked at $64K in Q1 2022.
- 108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2022.
Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.